FDA — authorised 14 September 1992
- Marketing authorisation holder: ORTHO BIOTECH
- Status: approved
🇺🇸 Orthoclone Okt3 in United States
FDA authorised Orthoclone Okt3 on 14 September 1992
Marketing authorisation
Orthoclone Okt3 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Orthoclone Okt3 approved in United States?
Yes. FDA authorised it on 14 September 1992.
Who is the marketing authorisation holder for Orthoclone Okt3 in United States?
ORTHO BIOTECH holds the US marketing authorisation.